Envision Pharma Group
Carolyn's strategic vision and experience will be integral to securing and creating top talent to advance Envision's priorities.
FAIRFIELD, CT / ACCESSWIRE / January 18, 2024 / Envision Pharma Group (Envision) has appointed Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team.
"We are thrilled to welcome Carolyn, who's proven herself as a people-leading expert in the life sciences industry, to Envision as our new Chief People Officer," says Howard Miller, CEO of Envision Pharma Group. "Her strategic vision aligns seamlessly with ours, and her exceptional leadership experience will play a crucial role in securing and retaining top talent to support our growth."
Carolyn's extensive experience and industry background were most recently put to use in her Chief Human Resources role at Omnicom Health Group, where she led a global team overseeing human resources strategy and operations for the healthcare division of Omnicom. In this role, Carolyn completed multiple company HR integrations and created a mobility program to retain top talent. Her additional experience leading global company initiatives includes leadership roles with Pfizer, Barclays Wealth, and QBE North America.
"I am excited to bring my talents to such an innovative and progressive company as Envision Pharma Group," adds Carolyn. "This is a unique opportunity for me to help accelerate the trajectory of an incredibly talented group of smart and dynamic individuals in the life sciences, an industry I love."
About Envision Pharma Group:
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 19 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.
Contact Information:
Colleen Carter
Associate Director, Communications, Office of CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856
SOURCE: Envision Pharma Group
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Asahi Refining29.8.2024 13:11:58 CEST | Press release
Asahi Refining Launches Fractional Gold Bar Product Line
Bahrain Economic Development Board29.8.2024 13:11:48 CEST | Press release
Bahrain Gears Up to Host the 2nd Edition of Fintech Forward in October
Beyond Oil Ltd.29.8.2024 13:11:47 CEST | Press release
Beyond Oil Featured in Television Report by Israel's Broadcast Network
Loar Group Inc.29.8.2024 13:11:47 CEST | Press release
Loar Holdings Inc. Completes Acquisition of Applied Avionics, Inc.
Holtway Global Hedge Pte. Ltd.29.8.2024 13:11:47 CEST | Press release
Empowering Global Investors with Access to High-Potential IPOs, Including Anticipated Opportunities in Space Technology
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom